COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 2883: Articles 28821-28830  | Next

Did elderly people living in small towns or rural areas suffer heavier disease burden during the COVID-19 epidemic?
Yu, X.
10.1101/2020.05.01.20087791 — Posted: 2020-05-06
Buying time: an ecological survival analysis of COVID-19 spread based on the gravity model
Vigdorovits, A.
10.1101/2020.05.01.20087569 — Posted: 2020-05-06
Evidence Supports a Causal Model for Vitamin D in COVID-19 Outcomes
Davies, G., Garami, A. R., Byers, J. C.
10.1101/2020.05.01.20087965 — Posted: 2020-05-06 Discussion: Onsite
Frequency of routine testing for SARS-CoV-2 to reduce transmissionamong workers
Chin, E. T., Lo, N. C., Huynh, B. Q., Murrill, M., Basu, S.
10.1101/2020.04.30.20087015 — Posted: 2020-05-06
Statistical Properties of Stepped Wedge Cluster-Randomized Trials in Infectious Disease Outbreaks
Kennedy-Shaffer, L., Lipsitch, M.
10.1101/2020.05.01.20087429 — Posted: 2020-05-06
Does BCG protect against SARS-CoV-2 infection ?: elements of proof.
Ouanes, Y., Bibi, M., Baradai, N., Boukhris, M., Chaker, K., Kacem, A., Hedhli, H., Mrad Deli, K., Sellami, A., Ben Rhouma, S., Nouira, Y.
10.1101/2020.05.01.20087437 — Posted: 2020-05-06
Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents
Zou, J., Bretin, A., Gewirtz, A.
10.1101/2020.05.01.20087478 — Posted: 2020-05-06
Effect of Temperature on the Transmission of COVID-19: A Machine Learning Case Study in Spain
Abdollahi, A., Rahbaralam, M.
10.1101/2020.05.01.20087759 — Posted: 2020-05-06 Discussion: Onsite
Control dynamics of the COVID-19 pandemic in China and South Korea
Moreira, J. M. L.
10.1101/2020.05.01.20087650 — Posted: 2020-05-06
Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19
McAndrews, K. M., Dowlatshahi, D. P., Hensel, J., Ostrosky-Zeichner, L. L., Papanna, R., LeBleu, V. S., Kalluri, R.
10.1101/2020.05.01.20087684 — Posted: 2020-05-06 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).